-
Synriam and Praziquantel: A New Combination Therapy for Schistosomiasis
The Persistent Challenge of Schistosomiasis Schistosomiasis remains one of the most neglected tropical diseases worldwide, affecting hundreds of millions of people across Africa, Asia, and South America. Despite decades of control efforts, this parasitic infection continues to burden resource-limited communities where access to clean water and adequate sanitation remains scarce. For years, praziquantel has stood as the primary weapon against schistosomiasis. It works, it is relatively safe, and it does not break the bank. But the drug has its problems. Most notably, praziquantel shows reduced efficacy against juvenile worms, particularly those in the early stages of development. This creates a frustrating gap: infected individuals carry immature parasites that survive standard…
-
Praziquantel
Welcome to the ultimate resource for Praziquantel CAS No. 55268-74-1, a highly effective anthelmintic trusted worldwide for its efficacy in treating parasitic infections. Manufactured by Henan Haitian Biotechnology Co., Ltd., a leader in pharmaceutical innovation, this product stands out for its quality, reliability, and compliance with global standards. Whether you’re a researcher, healthcare professional, or distributor, discover why our Praziquantel is the top choice for combating schistosomiasis and other parasitic diseases. What is Praziquantel CAS No. 55268-74-1? Name: Praziquantel Synonyms: 2-Cyclohexyl-carbonyl-1,3,4,6,7,11b-hexahydro-2H-pyrazine(2,1-a)isoquinoline-4-one Molecular Formula C19H24N2O2 Molecular Weight 312.41 CAS Registry Number 55268-74-1 EINECS 259-559-6 Praziquantel is used to treat infections caused by schistosoma worms, which enter the body through skin that…
